Sexually Transmitted Disease Testing Market Analysis by Disease (Human Immunodeficiency Virus, Herpes Simplex Virus, Human Papillomavirus, Chlamydia, Syphilis, Gonorrhea, Cancroid and Others); by Location (Laboratory, and Point of Care); and by Device (Laboratory Devices, and Point of Care Devices)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
-
Product Code:
RP-ID-10352435 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Category:
ICT & Telecom -
Publisher:
Pub-ID-54
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Sexually Transmitted Disease Testing Market Scope
Base Year |
2022 |
Forecast Year |
2023-2033 |
CAGR |
~6% |
Base Year Market Size (2023) |
~ USD 95,000 Million |
Forecast Year Market Size (2033) |
~ USD 145,000 Million |
Global Sexually Transmitted Disease Testing Market Highlights Over 2023 - 2033
The global sexually transmitted disease testing market is estimated to garner a revenue of USD 145,000Million by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of USD 95,000 Million in the year 2022. Higher instances of sexually transmitted disease (STD) in younger people is expected to drive the market growth. The adults of 15-24 years old holds the share of up to 50% of all new STD’s. Additionally, every 1 in 4 teens gets infected by STD every year.
GET A SAMPLE COPY OF THIS REPORT
Increasing sexual crimes against women is to propel the growth of the transmission of sexually transmitted infection among the women. According to the United Nations, 736 million women, at-least once in their lifetime have been gone through sexual intimate partner violence, non-partner violence or both. Furthermore, higher number of people working as sex workers, insurance covering the treatment of STD and increased case of STD is to propel the growth of global sexually transmitted disease testing market.
Global Sexually Transmitted Disease Testing Market: Growth Drivers and Challenges
Growth Drivers
-
Rising Cases of Sexually Transmitted Disease (STD)
Cases of sexually transmitted is rising owing to people active sexual life, choices of multiple partners and not using contraceptives. According to the World Health Organization (WHO), over 1 million sexually transmitted infections are transmitted all across the world.
-
Reimbursement Policy for Given for STD Testing and Treatment
Many countries are offering insurance or some sort of reimbursement to people. In 2019, the UPSTSTF task force added a full coverage of STDs in insurance plan.
-
Alarming Rise in Number of Rape Cases and Sexual Harassment
With the increasing rape crimes, the cases of sexually transmitted cases are also rising. According to the WHO, every 1 in 3 women experience sexual violence at-least once in their lifetime.
-
Growing Prostitution Across the World
Lack of enforcement by the law, increased human trafficking, is leading to growth of prostitution and more people involving into prostitution. Nearly, 40-42 million prostitutes are present worldwide, moreover, over 80% of global prostitute population are females.
-
Rise in Global Population of Young Adults
Young adults are socially more active, their broadened mentality leads them to get engage sexually with more partners, therefore, they are more susceptible to STD. By the statistics of the WHO, one in 20 young people catches STD each year. The rate is higher among the age group of 20-24 years.
Challenges
-
Social Stigma Associated with Sexually Transmitted Diseases
-
High Cost of Systems Required for STD Detection
-
Lack of Accurate Result by Detection Systems
Sexually transmitted disease is proven to be common disease, but the social stigma surrounding STDs still exists. Even after rise in educated population, people have false notion about sex or sex related problems. There is huge share of population, who hesitates to talk about sex or go for STD testing and treatment. Therefore, the rising social stigma is to hinder the market growth.
The sexually transmitted disease testing market is segmented and analyzed for demand and supply by disease into human immunodeficiency virus, herpes simplex virus, human papillomavirus, chlamydia, syphilis, gonorrhea, cancroid and others. Out of these, the chlamydia segment is to garner highest revenue by the end of 2033. Rising cases of chlamydia is to propel the growth of the segment. The center of disease control and prevention reported total 1,808,703 cases of chlamydia in 2019. According to the World Health Organization, in 2020 there were 129 million instances of chlamydia.
Global Sexually Transmitted Disease Testing Market Regional Synopsis
Regionally, the global sexually transmitted disease testing market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in Asia Pacific is projected to hold the largest market share by the end of 2033. Rising cases of rape and sexual harassment in the region is increasing the chances of sexually transmitted disease. In 2021, nearly 86 daily rapes and around 50 sexual crimes against women has been reported very hour in India. Moreover, in the Thailand, the population of sex worker is around 250,000 to 2 million. Higher cases reported of sexually transmitted disease. In 2021, over 20,000 deaths were caused by STD in China, and nearly 20 thousand people died of AIDS.
Market Segmentation
Our in-depth analysis of the global sexually transmitted disease testing market includes the following segments:
By Disease |
|
By Location |
|
By Device |
|
Customize this Report: Request Customization
Key Companies Dominating the Global Sexually Transmitted Disease Testing Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global sexually transmitted disease testing market that are included in our report are F. Hoffmann-La Roche Ltd., Abbott, bioMerieux, Becton Dickinson and Company, Quest Diagnostics, Thermo Fisher Scientific, Hologic Inc., Orasure Technologies, Inc., S&P Global, DiaSorin Molecular LLC., and others.
Global Sexually Transmitted Disease Testing Market: Latest Developments
-
March, 2021: Abbott collaborated with Johns Hopkins University, the University of Missouri-Kansas City (UMKC), National Institute of Allergy and Infectious Diseases (NIAID) and the Universite Protestante au Congo (UPC), and discovered a set of rare HIV carriers in the patient with no sign of symptoms.
-
April, 2019: Quest Diagnostics has launched three new sexually transmitted disease laboratory test packages. They are available online for consumers and are user-friendly.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
FREQUENTLY ASKED QUESTIONS
Rising cases of STD, sexual harassment, reimbursement schemes for STD testing and treatment and rising population of young adults are few factors likely to drive the market growth.
The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2033.
Social stigma of STD’s, expensive testing machines and failures in accuracy of test are some challenges, hampering the market growth.
The market in Asia Pacific is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
The major players in the market are F. Hoffmann-La Roche Ltd., Abbott, bioMerieux, Becton Dickinson and Company, Quest Diagnostics, Thermo Fisher Scientific, Hologic Inc., Orasure Technologies, Inc., S&P Global, DiaSorin Molecular LLC., and so on…
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by disease, location, device, and by region.
The chlamydia segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Please enter your personal details below
- F. Hoffmann-La Roche Ltd.
- Abbott
- bioMerieux
- Becton Dickinson and Company
- Quest Diagnostics
- Thermo Fisher Scientific
- Hologic Inc.
- Orasure Technologies Inc.
- S&P Global
- DiaSorin Molecular LLC.